[Jefferson Home] [Hospital] [Jefferson Pulse] [Employment] [Contact Us] [Search] [News]

TJU | JMC logo
The Bottom Line: Achieving Diabetes Treatment Goals
VOLUME 1 ISSUE 1
CASE KM
VOLUME 1 ISSUE 2
CASE WM
VOLUME 1 ISSUE 3
CASE SW
CASE SW
EDITORS
CME INFORMATION
DISCLAIMER
REFERENCES
VOLUME 1 ISSUE 4
CASE JJ
VOLUME 1 ISSUE 5
CASE PD
VOLUME 1 ISSUE 6
CASE MP


REFERENCES

VOLUME 1 ISSUE 3 CASE SW

  1. American College of Endocrinology. ACE position statement on insulin resistance. Available at: http://www.aace.com/pub/irscc/ACEPositionStatement.pdf.

  2. Braunwald E. Shattuck Lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–1369.

  3. National Heart, Lung, and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Joint National Committee for the prevention, identification, and treatment of high blood pressure (JNC-7). Available at: http://www.nhlbi.nih.gov/guidelines/hypertension/express.pdf.

  4. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2987.

  5. McLaughlin T, Abbasi F, Kim H-S, et al. Relationship between insulin resistance, weight loss, and coronary heart disease in healthy, obese women. Metabolism. 2002;7:795–800.

  6. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

  7. Golay A, Allaz A-F, Morel Y, et al. Similar weight loss with lowor-high-carbohydrate diets. Am J Clin Nutr. 1996;63:174–178.

  8. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157:657–67.

  9. American Diabetes Association. Clinical Practice Recommendations 2003. Diabetes Care 2003;26:1–156. Available at http://www.diabetes.org.

  10. American Association of Clinical Endocrinologists. American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control. Endocrine Pract 2002;8(suppl 1)5–11. Available at: http://www.aace.com/pub/dcc/dccwhitepaper.pdf.

  11. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003 Jul 9;290(2):199–206.

  12. Wyne KL, Drexler AJ, Miller JL, et al. Constructing an algorithm for managing type 2 diabetes. Focus on the role of thiazolidinediones. Postgrad Med. 2003 May;Spec No:63–72.

THIS ACTIVITY IS SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM
JOINTLY SPONSORED BY  |  TJU | JMC logo  |  BIOCENTRIC INC logo


The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.

Return to Thomas Jefferson University Home Page